DR.A.KELLES
The computed 12-month bankruptcy probability of DR.A.KELLES is 0.1% (very low). The 2024 annual accounts show equity of €1.43M and a net result of €243k. Equity is growing by ~51.1% per year across the filed fiscal years. Its solvency ranks better than 93% of 382 sector peers (fiscal year 2024). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1.43M |
| Net result | €243k |
| Staff (FTE) | 2.4 |
| Better than sector | 93% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 94.5% | 50.3% | |
| Net result | €243k | €72k | |
| Equity | €1.43M | €127k | |
| Gross operating margin | €586k | €179k | |
| Staff costs | €135k | €134k |
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €447k |
| Net profit | €243k |
| Cash flow | €311k |
| Staff costs | €135k |
| Income taxes | €110k |
| Dividends | - |
| Total assets | €1.51M |
| Equity | €1.43M |
| Debt | €83k |
| of which ≤ 1y | €83k |
| of which > 1y | - |
| Working capital | €1.03M |
| Employees (FTE) | 2.4 |
| 2024 | |
|---|---|
| Current ratio | 13.35 |
| Quick ratio | 13.35 |
| Working capital ratio | 68.0% |
| Solvency | 94.5% |
| Debt / equity | 0.06 |
| Long-term debt ratio | - |
| Interest coverage | 1210.98 |
| Gross margin | - |
| Net margin | - |
| ROA | 16.1% |
| ROE | 17.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.51M |
| Fixed assets | 21/28 | €400k |
| Tangible fixed assets | 22/27 | €400k |
| Financial fixed assets | 28 | €100 |
| Current assets | 29/58 | €1.11M |
| Amounts receivable within one year | 40/41 | €167k |
| Investments | 50/53 | €250k |
| Cash & bank | 54/58 | €688k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.51M |
| Equity | 10/15 | €1.43M |
| Contributions / capital | 10/11 | €12k |
| Reserves | 13 | €1.08M |
| Accumulated profits (losses) | 14 | €332k |
| Amounts payable | 17/49 | €83k |
| Amounts payable within one year | 42/48 | €83k |
| Trade debts payable within one year | 44 | €35k |
| Income statement | ||
| Gross operating margin | 9900 | €586k |
| Operating result | 9901 | €379k |
| Financial income | 75 | €7k |
| Financial charges | 65 | €369 |
| Result before taxes | 9903 | €353k |
| Income taxes | 67/77 | €110k |
| Net result for the period | 9904 | €243k |
| Result to be appropriated | 9905 | €243k |
-
KellesNiet statutair bestuurderState Gazette act 23465369 (20-12-2023)Current20-12-2023 → present
Permanent representatives (1)
-
KellesPermanent representativeState Gazette act 23465369 (20-12-2023)Permanent representative20-12-2023 → present
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 03-03-2004 |
| Status | Active |
| Postal code | 1020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11345B0223/00F005 | Flanders | 8,821 m² | 1 · 1.2 ha | - |
| 23093G0365/00K000 | Flanders | 1,172 m² | 1 · 194 m² | 8.5 m · 2 fl. |
| 21816G0092/00Y003 | Brussels | 260 m² | 1 · 112 m² | 12.9 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
20-12-2023 2 directors appointed
- Kelles, Niet statutair bestuurder
- Kelles, Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "KELLES Annemarie Gerarda Margaritha Antonia",
"address": "1861 Meise, Klepperstraat 17",
"birth_date": "1978-09-30",
"profession": null,
"birth_place": "Reet"
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering verleent, door een bijzondere stemming, volledige en algehele kwijting aan de ontslagnemende zaakvoerder/bestuurder voor haar mandaat.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "niet_statutair_bestuurder",
"person": {
"rrn": null,
"name": "Kelles",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "niet_statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "De algemene vergadering benoemt tot niet-statutaire bestuurder, met ingang van heden: Mevrouw Kelles, voornoemd, die deze benoeming aanvaardt en verklaart dat er tegen haar geen beroepsverbod werd uitgesproken.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Kelles",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "Zij wordt tevens aangesteld als vaste vertegenwoordiger voor de bestuursmandaten die de vennootschap zou opnemen.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Patrick Knevels",
"firm_city": null,
"firm_name": null,
"office_city": "Mortsel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-12-20",
"filing_date": "2023-12-16",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2023-02-20",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0863.784.901",
"name_full": "Dr. A. Kelles",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Patrick Knevels",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"afschrift - co\u00F6rdinatie met lijst"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | DR.A.KELLES |